Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis
- PMID: 26174490
- DOI: 10.1111/joim.12388
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis
Abstract
Background: Patients with psoriasis have an increased risk of type 2 diabetes. The gastrointestinal system plays a major role in normal glucose metabolism, and in healthy individuals, postprandial insulin secretion is largely mediated by the gut incretin hormones. This potentiation is termed the incretin effect and is reduced in type 2 diabetes. The impact of psoriasis on gastrointestinal factors involved in glucose metabolism has not previously been examined.
Objective: To investigate whether the incretin effect, gastrointestinal-mediated glucose disposal (GIGD) and/or secretion of glucagon and gut incretin hormones are impaired in normal glucose-tolerant patients with psoriasis.
Methods: Oral glucose tolerance tests and intravenous isoglycaemic glucose infusions were performed in 12 patients with moderate-to-severe psoriasis and 12 healthy matched control subjects.
Results: In patients with psoriasis, the incretin effect (39% vs. 57%, P = 0.02) and GIGD (53% vs. 61%, P = 0.04) were significantly reduced compared to control subjects. In addition, patients were glucose intolerant and showed exaggerated glucose-dependent insulinotropic polypeptide responses.
Conclusion: These novel findings support the notion that psoriasis is a prediabetic condition and suggest that gastrointestinal-related mechanisms are involved in the increased susceptibility to type 2 diabetes in patients with psoriasis.
Keywords: glucagon; incretin effect; incretin hormones; psoriasis; type 2 diabetes.
© 2015 The Association for the Publication of the Journal of Internal Medicine.
Similar articles
-
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.Diabetes Obes Metab. 2012 Jun;14(6):500-10. doi: 10.1111/j.1463-1326.2011.01549.x. Epub 2012 Jan 17. Diabetes Obes Metab. 2012. PMID: 22171657
-
Incretin hormones and beta cell function in chronic pancreatitis.Dan Med Bull. 2010 Jul;57(7):B4163. Dan Med Bull. 2010. PMID: 20591345 Review.
-
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.Diabetologia. 2018 Aug;61(8):1829-1837. doi: 10.1007/s00125-018-4633-z. Epub 2018 May 7. Diabetologia. 2018. PMID: 29732475
-
The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.Eur J Endocrinol. 2014 Sep;171(3):353-62. doi: 10.1530/EJE-14-0314. Epub 2014 Jun 16. Eur J Endocrinol. 2014. PMID: 24935932 Clinical Trial.
-
Fate of the beta-cell in the pathophysiology of type 2 diabetes.J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076. J Am Pharm Assoc (2003). 2009. PMID: 19801360 Review.
Cited by
-
Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes.Diabetes Metab Syndr Obes. 2021 May 26;14:2389-2397. doi: 10.2147/DMSO.S312420. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34079317 Free PMC article.
-
Diabetes and Psoriasis: Different Sides of the Same Prism.Diabetes Metab Syndr Obes. 2020 Oct 7;13:3571-3577. doi: 10.2147/DMSO.S273147. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33116708 Free PMC article. Review.
-
Psoriasis and Cardiovascular Risk: A Comprehensive Review.Adv Ther. 2020 May;37(5):2017-2033. doi: 10.1007/s12325-020-01346-6. Epub 2020 Apr 20. Adv Ther. 2020. PMID: 32314303 Free PMC article. Review.
-
Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis.Sci Rep. 2023 Nov 7;13(1):19313. doi: 10.1038/s41598-023-46795-5. Sci Rep. 2023. PMID: 37935955 Free PMC article.
-
Does HSP90 play an important role in psoriasis?Postepy Dermatol Alergol. 2021 Apr;38(2):319-326. doi: 10.5114/ada.2021.106210. Epub 2021 May 22. Postepy Dermatol Alergol. 2021. PMID: 36751545 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical